Lasa Supergenerics Ltd Financials
Company Logo

Lasa Supergenerics Ltd Financial Statement

Lasa Supergenerics Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Dec 2025
Revenue2.22
Operating Expense2.95
Net Profit-2.55
Net Profit Margin-114.86
Earning Per Share-0.51
EBIDTA-0.87
Effective Tax RateTBA

Lasa Supergenerics Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual142.45
Operating Expenses Annual136.18
Operating Profit Annual-4.39
Interest Annual2.69
Depreciation12.30
Net Profit Annual-14.76
Tax Annual-4.63

Lasa Supergenerics Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.61
Cash Flow from Operations-2.82
Cash Flow from Investing8.15
Cash Flow from Financing-5.66
Cash Flow at the End0.28

Lasa Supergenerics Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)7.92
PBIT Margin (%)-0.72
PBT Margin (%)-0.45
Net PROFIT Margin (%)-10.36
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-14.40
Total Debt / Equity (X)0.13
Asset Turnover Ratio (%)1.39

Lasa Supergenerics Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual67.99
Total Current Assets Annual32.51
Non Current Assets Annual69.02
Total Shareholders Funds Annual83.71
Total Assets Annual101.53

Lasa Supergenerics Ltd Earning Calls

No Data Availabe

FAQS on Lasa Supergenerics Ltd Financials

As of Mar 7, 2026, Lasa Supergenerics Ltd has a market capitalization of 84.42 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Lasa Supergenerics Ltd is with a debt-to-equity ratio of 0.03.

In FY 2025 , Lasa Supergenerics Ltd recorded a total revenue of approximately 142.45 Cr marking a significant milestone in the company's financial performance.

Lasa Supergenerics Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and 0.0% annually, respectively..

Lasa Supergenerics Ltd's current PE ratio is -5.72.

Lasa Supergenerics Ltd's ROCE averaged -7.1% from the FY ending March 2023 to 2025, with a median of -7.1%. It peaked at -1.2% in March 2025, reflecting strong capital efficiency over the period..

Lasa Supergenerics Ltd's latest EBIT is Rs. -16.69 Cr, surpassing the average EBIT of Rs. -23.99 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions